Shionogi

Shionogi & Company, Limited, established in 1878, is a prominent Japanese pharmaceutical company operating within the global Healthcare and Pharmaceuticals sectors. The company is recognized for its contributions to medical advancements, notably for developing the widely used drug Crestor. Shionogi's operations extend to medical supply and brand name utilization, underscoring its multifaceted role in the healthcare industry. With a history spanning over a century, the company has built a legacy of innovation and commitment to patient well-being.

Employing between 1,000 and 5,000 individuals, Shionogi generated revenue of $74.4M in its last reported fiscal year, which concluded on March 31st. This financial performance reflects its established market presence and operational capacity. The company's dedication to its workforce and operational excellence is a key factor in its sustained success. For insights into the individuals driving its mission, one can Meet Shionogi's team to learn more about their leadership and expertise.

Shionogi's strategic positioning is further indicated by its presence in various market segments, including B2B services, as suggested by its hashtags. While specific competitor data is not provided, its long-standing history and product development indicate a competitive standing within the pharmaceutical landscape. The company's digital presence is accessible via www.shionogi.tv, serving as a portal for information and engagement.